New York, February 26, 2018:
In Vitro Diagnostics IVD Market 2018
The Global In Vitro Diagnostics IVD Market is expected to exceed more than US$ 77 billion by 2022 and will grow at a CAGR of more than 5% in the given forecast period.
The scope of the report includes a detailed study of global and regional markets for Global In Vitro Diagnostics IVD Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Affymetrix, Inc., AlereInc, Biomerieux, Danaher Corporation., Roche Diagnostics, Becton Dickinson and Company, Bio-Rad Laboratories, Inc., Abbott Laboratories, Bayer AG., Arkray, Inc., Sysmex Corporation, Johnson & Johnson Pvt. Ltd. And Siemens AG. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
You Can Find Full Report @: https://www.marketresearchengine.com/reportdetails/global-in-vitro-diagnostics-ivd-market
The Global In Vitro Diagnostics IVD Market has been segmented as below:
By Product Analysis
• Software & Services
By Technique Analysis
o Enzyme-Linked Immunosorbent Assay (ELISA)
o Enzyme-Linked ImmunoSpot (ELISPOT)
o Rapid Tests
o Western blot
o Radioimmunoassay (RIA)
• Blood Testing
• Molecular Diagnostics
o Polymerize Chain Reaction (PCR)
o Isothermal Nucleic Acid Technology (INAAT)
o DNA diagnostics
• Tissue Diagnostics
• Clinical Chemistry
o Basic metabolic panel
o Lipid profile
o Liver panel
o Electrolyte panel
o Thyroid function panel
o Speciality chemicals
• Other IVD Techniques
By Application Analysis
• Infectious Diseases
• Cardiac Diseases
• Immune System Disorders
• Nephrological Diseases
• Gastrointestinal Diseases
• Other Indications
By End User Analysis
• Standalone Laboratory
• Academic & Medical Schools
• Point of Care
By Regional Analysis
• North America
• Rest of the World
This report provides:
1) An overview of the global market for In Vitro Diagnostics IVD and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for In Vitro Diagnostics IVD.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
The major driving factors of Global In Vitro Diagnostics IVD Market are as follows:
• Increasing demand for technically advanced diagnostic devices
• Technical expansion to develop high sensitivity point of care hematology testing
• Improved disposable income of customers gives high expansion potential for IVD market
The restraining factors of Global In Vitro Diagnostics IVD Market are as follows:
• Strict government rules
• Inauspicious reimbursement policies
Ask Sample Report: https://www.marketresearchengine.com/reportdetails/global-in-vitro-diagnostics-ivd-market
Table of Contents
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Industry Trends
6.2 Industry Trends
6.2.1 Automation of Clinical Laboratory Techniques
6.2.2 Microfluidics-Based Poc and Loc Diagnostic Devices for Laboratory Testing
6.2.3 Rise in Reagent Rental Agreements
6.3 Regulatory Overview
6.3.1 North America
7 Global In Vitro Diagnostics Market, By Product & Service
8 Global In Vitro Diagnostics Market, By Technology
9 Global In Vitro Diagnostics Market, By Application
10 Global In Vitro Diagnostics Market, By End User
11 Global In Vitro Diagnostics Market, By Region
12 Competitive Landscape
13 Company Profiles
13.2 ABBott Laboratories, Inc.
13.3 Becton, Dickinson and Company
13.4 Biomérieux SA
13.5 Bio-Rad Laboratories, Inc.
13.6 Danaher Corporation
13.7 Johnson & Johnson
13.8 Roche Diagnostics
13.9 Siemens AG
13.10 Sysmex Corporation
13.11 Thermo Fisher Scientific, Inc.
13.12 Ortho-Clinical Diagnostics, Inc.
13.13 Qiagen N.V.
13.14 Diasorin S.P.A.
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States